The wellness world is eager for RFK Jr.'s promised move on peptides : NPR FDA to weigh easing limits on unproven peptides favored by RFK Jr. and MAHA supporters PBS News BPC 157: The peptide with big claims and scant evidence STAT BPC 157 has a decades long safety record with zero deaths or hospitalizations. Yet, it's unapproved because the FDA process is too expensive and the business model doesn't allow for profit. Approved People are turning themselves into lab rats': the injectable peptides craze sweeping the US Well actually The Guardian The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York